Tumor and Serum DNA Methylation in Women Receiving Preoperative Chemotherapy with or without Vorinostat in TBCRC008

BACKGROUND: Methylated gene markers have shown promise in predicting breast cancer outcomes and treatment response. We evaluated whether baseline and change in tissue and serum methylation would predict pathological complete response (pCR) in patients with HER2-negative early breast cancer undergoin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res Treat
Autori principali: Connolly, Roisin M., Fackler, Mary Jo, Zhang, Zhe, Zhou, Xian C., Goetz, Matthew P., Boughey, Judy C., Walsh, Bridget, Carpenter, John T., Storniolo, Anna Maria, Watkins, Stanley P., Gabrielson, Edward W., Stearns, Vered, Sukumar, Saraswati
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793219/
https://ncbi.nlm.nih.gov/pubmed/28918548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4503-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi